These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19050708)

  • 1. Expediting the availability of drugs for US patients with cancer.
    Farrell AT; Pazdur R; von Eschenbach AC
    Nat Clin Pract Urol; 2008 Dec; 5(12):654-6. PubMed ID: 19050708
    [No Abstract]   [Full Text] [Related]  

  • 2. Hurry up and wait: is accelerated approval of new cancer drugs in the best interests of cancer patients?
    Schilsky RL
    J Clin Oncol; 2003 Oct; 21(20):3718-20. PubMed ID: 12963701
    [No Abstract]   [Full Text] [Related]  

  • 3. The second wave in kinase cancer drugs.
    Garber K
    Nat Biotechnol; 2006 Feb; 24(2):127-30. PubMed ID: 16465146
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA
    Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
    [No Abstract]   [Full Text] [Related]  

  • 5. Swimming upstream: an advocate reflects on cancer research and social realities.
    Mayer M
    J Clin Oncol; 2008 Jun; 26(16):2783-6. PubMed ID: 18509190
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory watch: Why do oncology drugs fail to gain US regulatory approval?
    Khozin S; Liu K; Jarow JP; Pazdur R
    Nat Rev Drug Discov; 2015 Jul; 14(7):450-1. PubMed ID: 26000722
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat bite: Currently approved oncology drugs.
    J Natl Cancer Inst; 2007 Mar; 99(5):344. PubMed ID: 17341722
    [No Abstract]   [Full Text] [Related]  

  • 9. A Significant Anticancer Drug Approval Lag Between Japan and the United States Still Exists for Minor Cancers.
    Yamashita K; Kaneko M; Narukawa M
    Clin Pharmacol Ther; 2019 Jan; 105(1):153-160. PubMed ID: 29882302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volleys in the cancer war. Has the 30-year enterprise been wrongheaded from the start?
    Sobel RK
    US News World Rep; 2001 Jun; 130(24):42-3. PubMed ID: 11430211
    [No Abstract]   [Full Text] [Related]  

  • 11. I-SPY 2 may change how clinical trials are conducted: researchers aim to accelerate approvals of cancer drugs.
    Printz C
    Cancer; 2013 Jun; 119(11):1925-7. PubMed ID: 23695808
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted agents: the rules of combination.
    Kwak EL; Clark JW; Chabner B
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priority-setting decisions for new cancer drugs.
    Millar A
    Lancet; 2002 Apr; 359(9316):1524; author reply 1524-5. PubMed ID: 11988280
    [No Abstract]   [Full Text] [Related]  

  • 14. Priority-setting decisions for new cancer drugs.
    Wheatley K; Djulbegovic B; Glasmacher A
    Lancet; 2002 Apr; 359(9316):1525. PubMed ID: 11988282
    [No Abstract]   [Full Text] [Related]  

  • 15. While We're at It, Let's Whack the FDA.
    Chabner BA
    Oncologist; 2016 Mar; 21(3):259-60. PubMed ID: 26869585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ODAC Chronicles: Part 6a. ODAC's structure and function.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):573-7. PubMed ID: 16111457
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncology approvals in 2020: a year of firsts in the midst of a pandemic.
    Amiri-Kordestani L; Pazdur R
    Nat Rev Clin Oncol; 2021 Mar; 18(3):129-130. PubMed ID: 33514911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are european cancer patients getting a fair deal?
    McVie JG
    Ann Oncol; 2001 Aug; 12(8):1033-5. PubMed ID: 11583176
    [No Abstract]   [Full Text] [Related]  

  • 19. Why we're losing the war on cancer (and how to win it).
    Leaf C
    Fortune; 2004 Mar; 149(6):76-82, 84-6, 88 passim. PubMed ID: 15069734
    [No Abstract]   [Full Text] [Related]  

  • 20. US Food and Drug Administration approves first cancer treatment for any solid tumors with specific biomarker.
    Cancer; 2017 Oct; 123(19):3652-3653. PubMed ID: 28940329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.